1)- Yu Yang, Mengqing Ma, Jian Zhang, Shiyu Jin, Dingxin Zhang, Xianhe Lin. Triglyceride-glucose index in the prediction of clinical outcomes after successful recanalization for coronary chronic total occlusions.Cardiovascular diabetology. 2023, 22 (1): 304
2)- Shiyi Tao, Lintong Yu, Jun Li, Li Huang, Xuanchun Huang, Wenjie Zhang, Zicong Xie, Yuqing Tan, Deshuang Yang. Association between the triglyceride-glucose index and 1-year major adverse cardiovascular events in patients with coronary heart disease and hypertension.Cardiovascular diabetology. 2023, 22 (1): 305
4)- Rui Zheng, Songzan Qian, Yiyi Shi, Chen Lou, Honglei Xu, Jingye Pan. Association between triglyceride-glucose index and in-hospital mortality in critically ill patients with sepsis: analysis of the MIMIC-IV database.Cardiovascular diabetology. 2023, 22 (1): 307
6)- Jiahao Dou, Chen Guo, Yawen Wang, Zihe Peng, Ruiyun Wu, Qiangqiang Li, Hong Zhao, Shoufang Song, Xuelu Sun, Jin Wei. Association between triglyceride glucose-body mass and one-year all-cause mortality of patients with heart failure: a retrospective study utilizing the MIMIC-IV database.Cardiovascular diabetology. 2023, 22 (1): 309
7)- Damien Denimal, Sarah Béland-Bonenfant, Jean-Paul Pais-de-Barros, Alexia Rouland, Benjamin Bouillet, Laurence Duvillard, Bruno Vergès, Jean-Michel Petit. Plasma ceramides are associated with MRI-based liver fat content but not with noninvasive scores of liver fibrosis in patients with type 2 diabetes.Cardiovascular diabetology. 2023, 22 (1): 310
8)- Liao Tan, Yubo Liu, Jie Liu, Guogang Zhang, Zhaoya Liu, Ruizheng Shi. Association between insulin resistance and uncontrolled hypertension and arterial stiffness among US adults: a population-based study.Cardiovascular diabetology. 2023, 22 (1): 311
9)- Sarah Costantino, Alessandro Mengozzi, Srividya Velagapudi, Shafeeq Ahmed Mohammed, Era Gorica, Alexander Akhmedov, Alessia Mongelli, Nicola Riccardo Pugliese, Stefano Masi, Agostino Virdis, Andreas Hülsmeier, Christian Matthias Matter, Thorsten Hornemann, Giovanni Melina, Frank Ruschitzka, Thomas Felix Luscher, Francesco Paneni. Treatment with recombinant Sirt1 rewires the cardiac lipidome and rescues diabetes-related metabolic cardiomyopathy.Cardiovascular diabetology. 2023, 22 (1): 312
11)- Dídac Mauricio, Mònica Gratacòs, Josep Franch-Nadal. Diabetic microvascular disease in non-classical beds: the hidden impact beyond the retina, the kidney, and the peripheral nerves.Cardiovascular diabetology. 2023, 22 (1): 314
12)- Weimin Cai, Yaling Li, Kun Guo, Xiao Wu, Chao Chen, Xinran Lin. Association of glycemic variability with death and severe consciousness disturbance among critically ill patients with cerebrovascular disease: analysis of the MIMIC-IV database.Cardiovascular diabetology. 2023, 22 (1): 315
13)- Robert J Mentz, Stephen A Brunton, Janani Rangaswami. Sodium-glucose cotransporter-2 inhibition for heart failure with preserved ejection fraction and chronic kidney disease with or without type 2 diabetes mellitus: a narrative review.Cardiovascular diabetology. 2023, 22 (1): 316
15)- Katarzyna Nabrdalik, Hanna Kwiendacz, Krzysztof Irlik, Mirela Hendel, Karolina Drożdż, Agata M Wijata, Jakub Nalepa, Oliwia Janota, Wiktoria Wójcik, Janusz Gumprecht, Gregory Y H Lip. Machine learning identification of risk factors for heart failure in patients with diabetes mellitus with metabolic dysfunction associated steatotic liver disease (MASLD): the Silesia Diabetes-Heart Project.Cardiovascular diabetology. 2023, 22 (1): 318
16)- Xi Tan, Yuanjie Liang, Jigar R Rajpura, Larisa Yedigarova, Josh Noone, Lin Xie, Silvio Inzucchi, Adam de Havenon. Once-weekly glucagon-like peptide-1 receptor agonists vs dipeptidyl peptidase-4 inhibitors: cardiovascular effects in people with diabetes and cardiovascular disease.Cardiovascular diabetology. 2023, 22 (1): 319
17)- Jiaqi Chen, Kangxiang Wu, Yiying Lin, Mingyuan Huang, Shanghe Xie. Association of triglyceride glucose index with all-cause and cardiovascular mortality in the general population.Cardiovascular diabetology. 2023, 22 (1): 320
18)- Lin Na, Wenjing Cui, Xinqi Li, Jing Chang, Xin Xue. Association between the triglyceride-glucose index and left ventricular global longitudinal strain in patients with coronary heart disease in Jilin Province, China: a cross-sectional study.Cardiovascular diabetology. 2023, 22 (1): 321
20)- Tadeusz Osadnik, Dariusz Nowak, Kamila Osadnik, Marek Gierlotka, Adam Windak, Tomasz Tomasik, Mirosław Mastej, Beata Łabuz-Roszak, Kacper Jóźwiak, Gregory Y H Lip, Dimitri P Mikhailidis, Peter P Toth, Naveed Sattar, Marcin Goławski, Jacek Jóźwiak, Maciej Banach, . Association of body mass index and long-term mortality in patients from nationwide LIPIDOGRAM 2004-2015 cohort studies: no obesity paradox?Cardiovascular diabetology. 2023, 22 (1): 323
21)- Ovidio De Filippo, Fabrizio D'Ascenzo, Mario Iannaccone, Maurizio Bertaina, Attilio Leone, Irene Borzillo, Emanuele Ravetti, Andrea Solano, Ilaria Pagliassotto, Marco Nebiolo, Francesco Bruno, Federico Giacobbe, Saverio Muscoli, Silvia Monticone, Maria Felice Brizzi, Giuseppe Biondi Zoccai, Gaetano Maria De Ferrari. Safety and efficacy of bempedoic acid: a systematic review and meta-analysis of randomised controlled trials.Cardiovascular diabetology. 2023, 22 (1): 324
23)- Jinluan Chen, Banafsheh Arshi, Komal Waqas, Tianqi Lu, Daniel Bos, M Arfan Ikram, André G Uitterlinden, Maryam Kavousi, M Carola Zillikens. Advanced glycation end products measured by skin autofluorescence and subclinical cardiovascular disease: the Rotterdam Study.Cardiovascular diabetology. 2023, 22 (1): 326
25)- Sara W Quist, Alexander V van Schoonhoven, Stephan J L Bakker, Michał Pochopień, Maarten J Postma, Jeanni M T van Loon, Jeroen H J Paulissen. Cost-effectiveness of finerenone in chronic kidney disease associated with type 2 diabetes in The Netherlands.Cardiovascular diabetology. 2023, 22 (1): 328
26)- Kamel Mohammedi, Audrey Cordon, Vincent Rigalleau, Ninon Foussard, Céline Bairras-Martin, Thierry Couffinhal, Julien Bezin, Antoine Benard. Cost-effectiveness of screening of coronary artery disease in patients with type 2 diabetes at a very high cardiovascular risk (SCADIAB) study. Updated study design: emulation of a randomised target trial using electronic health records.Cardiovascular diabetology. 2023, 22 (1): 329
27)- Akihiko Koshino, Brendon L Neuen, Niels Jongs, Carol Pollock, Peter J Greasley, Eva-Marie Andersson, Ann Hammarstedt, Cecilia Karlsson, Anna Maria Langkilde, Takashi Wada, Hiddo J L Heerspink. Effects of dapagliflozin and dapagliflozin-saxagliptin on erythropoiesis, iron and inflammation markers in patients with type 2 diabetes and chronic kidney disease: data from the DELIGHT trial.Cardiovascular diabetology. 2023, 22 (1): 330
28)- Weijie Wang, Yilan Li, Yanxiu Zhang, Tao Ye, Kui Wang, Shuijie Li, Yao Zhang. SIRT1 mediates the inhibitory effect of Dapagliflozin on EndMT by inhibiting the acetylation of endothelium Notch1.Cardiovascular diabetology. 2023, 22 (1): 331
30)- Yu Zhang, Ce Zhang, Lin Jiang, Lianjun Xu, Jian Tian, Xueyan Zhao, Dong Wang, Yin Zhang, Kai Sun, Channa Zhang, Bo Xu, Wei Zhao, Rutai Hui, Runlin Gao, Jizheng Wang, Xinxing Feng, Jinqing Yuan, Lei Song. An elevated triglyceride-glucose index predicts adverse outcomes and interacts with the treatment strategy in patients with three-vessel disease.Cardiovascular diabetology. 2023, 22 (1): 333
32)- Marta Lopez-Yus, Carmen Casamayor, Juan Jose Soriano-Godes, Sofia Borlan, Yolanda Gonzalez-Irazabal, Maria Pilar Garcia-Sobreviela, Beatriz Garcia-Rodriguez, Raquel Del Moral-Bergos, Pilar Calmarza, Jose Maria Artigas, Silvia Lorente-Cebrian, Vanesa Bernal-Monterde, Alejandro Sanz-Paris, Jose M Arbones-Mainar. Isthmin-1 (ISM1), a novel adipokine that reflects abdominal adipose tissue distribution in individuals with obesity.Cardiovascular diabetology. 2023, 22 (1): 335
34)- Irene Santos-Pardo, Nils Witt, Oskar Angerås, Thomas Nyström. Effects of exenatide on coronary stent's endothelialization in subjects with type 2 diabetes: a randomized controlled trial. The Rebuild study.Cardiovascular diabetology. 2023, 22 (1): 337
37)- Jesús F García-Gavilán, Nancy Babio, Estefanía Toledo, Zhila Semnani-Azad, Cristina Razquin, Courtney Dennis, Amy Deik, Dolores Corella, Ramón Estruch, Emilio Ros, Montserrat Fitó, Fernando Arós, Miquel Fiol, José Lapetra, Rosa Lamuela-Raventos, Clary Clish, Miguel Ruiz-Canela, Miguel Ángel Martínez-González, Frank Hu, Jordi Salas-Salvadó, Marta Guasch-Ferré. Olive oil consumption, plasma metabolites, and risk of type 2 diabetes and cardiovascular disease.Cardiovascular diabetology. 2023, 22 (1): 340
38)- Hui Zhou, Xiong Ding, Yulong Lan, Shuohua Chen, Shouling Wu, Dan Wu. Multi-trajectories of triglyceride-glucose index and lifestyle with Cardiovascular Disease: a cohort study.Cardiovascular diabetology. 2023, 22 (1): 341
40)- Tracey G Simon, Fahim Ebrahimi, Bjorn Roelstraete, Hannes Hagström, Johan Sundström, Jonas F Ludvigsson. Incident cardiac arrhythmias associated with metabolic dysfunction-associated steatotic liver disease: a nationwide histology cohort study.Cardiovascular diabetology. 2023, 22 (1): 343
42)- Chung-Yen Lu, Hsiao-Hui Chen, Kuan-Hui Chi, Pei-Chun Chen. Obesity indices and the risk of total and cardiovascular mortality among people with diabetes: a long-term follow-up study in Taiwan.Cardiovascular diabetology. 2023, 22 (1): 345
43)- Nan Zhang, Xiying Chi, Ziyi Zhou, Yun Song, Shuqun Li, Jiafeng Xu, Jianping Li. Triglyceride-glucose index is associated with a higher risk of stroke in a hypertensive population.Cardiovascular diabetology. 2023, 22 (1): 346
46)- Francesca Cinti, Lucia Leccisotti, Gian Pio Sorice, Umberto Capece, Domenico D'Amario, Margherita Lorusso, Shawn Gugliandolo, Cassandra Morciano, Andrea Guarneri, Maria Angela Guzzardi, Teresa Mezza, Amedeo Capotosti, Luca Indovina, Pietro Manuel Ferraro, Patricia Iozzo, Filippo Crea, Alessandro Giordano, Andrea Giaccari. Dapagliflozin treatment is associated with a reduction of epicardial adipose tissue thickness and epicardial glucose uptake in human type 2 diabetes.Cardiovascular diabetology. 2023, 22 (1): 349
47)- Josep Iglesies-Grau, Ana Garcia-Alvarez, Belén Oliva, Guiomar Mendieta, Inés García-Lunar, José J Fuster, Ana Devesa, Cristina Pérez-Herreras, Antonio Fernández-Ortiz, Ramon Brugada, Borja Ibanez, Rodrigo Fernandez-Jimenez, Valentin Fuster. Early insulin resistance in normoglycemic low-risk individuals is associated with subclinical atherosclerosis.Cardiovascular diabetology. 2023, 22 (1): 350